# OnCo record nct06695845 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06695845/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06695845", "NCT06695845" ;
  schema:name "A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors"@en ;
  schema:alternateName "DiscovHER PAN-206"@en ;
  schema:description "A phase 2 trial of Zanidatamab in oesophageal cancer and colorectal cancer, run by Jazz Pharmaceuticals, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06695845/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06695845> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-01-14" ;
  onco:cancers <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/her2-amplified-colorectal/>, <https://onco.cc/cancers/her2-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:drugs <https://onco.cc/drugs/zanidatamab/> ;
  onco:companies <https://onco.cc/companies/jazz/> .